Dementia Prevention
Nearly half of dementia cases are tied to 14 things that can be changed, mostly the same things that protect your heart, plus hearing, vision and the company you keep. Only one of them, lowering high blood pressure, has a large randomised trial showing fewer dementia diagnoses. For the rest the case rests on a strong risk map and trials that improve thinking skills. Most brain supplements and apps sold for dementia either failed when tested or were never properly tested, and the one trial of a "brain diet" was null.
Treat midlife blood pressure, cholesterol and diabetes properly, get your hearing and eyes checked and fix what you find, move every day, sleep regularly and get checked for sleep apnea, and stay socially connected. Do these for their own sake. Any dementia benefit comes on top. Skip memory supplements and brain-training apps.
What "nearly half" means, and what it doesn't
The headline figure comes from the 2024 Lancet Commission on dementia. It estimates that removing 14 modifiable risk factors would prevent or delay about 45% of dementia cases worldwide.[1]
| Life stage | Risk factor | Risk multiplier | How common | Share of cases |
|---|---|---|---|---|
| Early life (<45) | Less education | 1.6× | 23% | 5% |
| Midlife (45–65) | Hearing loss | 1.4× | 59% | 7% |
| Midlife | High LDL cholesterol | 1.3× | 77% | 7% |
| Midlife | Depression | 2.2× | 7% | 3% |
| Midlife | Traumatic brain injury | 1.7× | 12% | 3% |
| Midlife | Physical inactivity | 1.2× | 28% | 2% |
| Midlife | Smoking | 1.3× | 22% | 2% |
| Midlife | Diabetes | 1.7× | 9% | 2% |
| Midlife | Hypertension | 1.2× | 31% | 2% |
| Midlife | Obesity | 1.3× | 13% | 1% |
| Midlife | Excessive alcohol | 1.2× | 13% | 1% |
| Late life (65+) | Social isolation | 1.6× | 24% | 5% |
| Late life | Air pollution (fine particulates) | 1.1× | 75% | 3% |
| Late life | Untreated vision loss | 1.5× | 13% | 2% |
| All 14 combined | 45% |
The ranking follows how common a factor is, not how dangerous it is. Hearing loss tops the list with an ordinary risk multiplier of 1.4, because 59% of people in midlife have some. Depression carries the largest individual risk (2.2×) but affects 7% of people, so it accounts for only 3% of cases. Blood pressure's small share does not mean treating it pays little, as the next section shows.
Ten of the 14 are midlife factors. The window that matters most is roughly ages 45 to 65.
The Commission's model is a careful synthesis of observational studies, not a result from trials. The share figures assume each link is causal, and for some it may not be. The Commission itself warns that late-life depression may be an early symptom of dementia rather than a cause, and these are population averages, not personal predictions. When the full 14-factor model was re-tested in a single long-running cohort of 5,526 Americans, only three factors held up: hearing loss and diabetes as risks, and midlife high blood pressure, oddly, in the protective direction. That analysis is a conference abstract, so treat it as a warning flag rather than a refutation.[2]
Blood pressure: the one lever with a positive dementia trial
Lowering high blood pressure is the only intervention so far shown, in a large randomised trial built around dementia, to reduce diagnoses. In 326 villages in rural China, 33,995 adults aged 40 and over with uncontrolled high blood pressure were randomised by village. One group got a programme in which trained community health workers started and adjusted blood-pressure drugs, aiming for below 130/80 mmHg. The other got usual care. After four years systolic pressure was 22 mmHg lower and dementia was about 15% lower, with fewer serious side effects, not more.[3] The trial was open-label, in one population, with a bigger blood-pressure drop than most real-world care achieves.
The earlier American trial pointed the same way, less clearly. Aiming systolic pressure below 120 rather than 140 mmHg in 9,361 adults cut mild cognitive impairment by about a fifth. Its main dementia result, a 17% reduction, was not statistically significant: the range of plausible effects still included none. The trial stopped early because of its cardiovascular benefit and was probably too small to settle dementia.[4] Seven years on, dementia on its own was still not significantly reduced.[5]
The Commission recommends systolic pressure below 130 mmHg from age 40, if you tolerate it. Lifestyle comes first: the DASH eating pattern, exercise and weight loss, with medication if needed. See Blood pressure.
Hearing and vision: the biggest share, an unproven fix
Hearing loss accounts for the largest share of cases in the Commission's model, level with high LDL cholesterol, and most people leave it untreated for years. Whether hearing aids prevent dementia is not yet known.
The one randomised trial gave 977 American adults aged 70 to 84 either hearing aids with counselling or health education. Over three years, cognitive decline was essentially identical in the two groups. The much-quoted 48% slowing came only from a higher-risk subgroup who were older and declining faster, which makes it a lead, not a result.[6]
The more encouraging data is observational. In 2,777 Australians aged around 75 with self-reported hearing problems, followed for seven years, dementia occurred in 5.0% of those prescribed hearing aids against 7.5% of those not. That is roughly 25 fewer cases per 1,000 people. Risk appeared to fall further the more the aids were actually worn, though the authors cannot rule out confounding.[7] The case for treating hearing loss rests on how common it is and how harmless the fix is. A hearing aid that lives in a drawer doesn't count.
If you pass a standard hearing test but struggle in noisy rooms, ask for extended high-frequency audiometry, which tests above the usual 8 kHz ceiling; one small, not-yet-peer-reviewed preprint suggests it explains that difficulty better.[8] See Hearing.
Vision loss is also linked to dementia, but whether correcting it helps is unproven. Pooled studies of cataract surgery disagree: one found no significant reduction in dementia,[9] another about 25% less long-term cognitive decline, but at very low to low certainty and with no randomised trial.[10] Correct your vision for its own sake. See Vision.
Diabetes, weight and cholesterol
The links are consistent, but no trial has yet shown that treating diabetes, weight or cholesterol prevents dementia.
Type 2 diabetes raises dementia risk by roughly 70% in the Commission's pooled estimate. That is substantial, but short of the "doubles your risk" often quoted. Well-controlled diabetes does much less damage than uncontrolled diabetes, but intensive control is no better for dementia than standard control.[11] Without diabetes, an HbA1c (the three-month blood-sugar average) below 5.7% is normal. With diabetes, agree a target with your clinician. For many adults it is below 7%, and people who are frail, have cognitive or functional limitations, or have several serious illnesses are usually given looser goals, such as below 8%. Episodes of low blood sugar are themselves linked to dementia. With insulin or sulfonylureas, driving HbA1c to near-normal is risky: in the ACCORD trial, intensive lowering raised mortality.[12][13][14]
Weight. Midlife obesity is linked to about 30% higher dementia risk. There is no good evidence that belly fat matters more than overall weight. After about 60 the picture flips, with higher weight linked to slightly lower risk, probably because weight often falls in the years before diagnosis.[15] Keep weight and waist in check from midlife.
Cholesterol. High LDL ties with hearing loss for the largest share of cases, mostly because three-quarters of middle-aged adults have raised levels. Genetic studies link lifelong lower cholesterol through the statin target to less dementia.[16] The first large statin trial with dementia in its main outcome, though, was neutral. In 9,971 adults aged 70 or older without cardiovascular disease, diabetes or dementia, atorvastatin cut major cardiovascular events by about 30% over about six years. It did not lengthen survival free of death, dementia or disability, and the published results report dementia only within that combined outcome.[17] Take a statin when your heart and arteries need one. Don't start one late in life to prevent dementia. See Lipid management.
Exercise: good for thinking, unproven for dementia
In randomised trials, exercise improves thinking skills in older adults. No trial has yet shown it reduces dementia. The best evidence is a 2026 analysis of 227 randomised trials in adults over 60 without dementia: exercise improved planning and self-control, memory and processing speed. Adding cognitive training or other lifestyle parts beat control only for memory; in a combined analysis of all the trials it came out ahead of exercise alone for planning and processing speed, but the authors call its added benefit unsettled.[18] Strength training gives modest gains in working memory and mental flexibility, no more than other exercise, on low-certainty evidence.[19]
The popular claim that aerobic exercise grows the hippocampus, the brain's memory centre, comes from one trial in 120 older adults that found about 2% growth.[20] Pooled trials have not confirmed it. Across eight trials in 554 healthy older adults, fitness improved but hippocampal volume did not change significantly.[21]
Combined lifestyle programmes help a little. A Finnish two-year programme of diet, exercise, brain training and risk-factor checks in 1,260 at-risk older adults improved cognition by a small absolute amount.[22] Its American successor compared a structured and a self-guided version of a similar programme, including the MIND diet, in 2,111 at-risk adults aged 60 to 79. Both improved; the structured group slightly more, by a margin of unclear clinical meaning, and equally in carriers and non-carriers of APOE ε4, the main genetic risk variant for Alzheimer's. There was no do-nothing group, and the Alzheimer's Association funded and helped run the trial.[23]
Sitting matters separately, though the evidence is observational. In older adults followed for seven years, more daily sitting went with faster shrinkage of the hippocampus and with declines in naming and processing speed, even after allowing for how much they exercised; and, in a one-time snapshot, more sitting also went with a brain-scan pattern typical of Alzheimer's disease.[24] A review of 33 studies points the same way but calls the overall evidence limited and mixed.[25] In about 14,400 British adults aged 45–81, more sitting went with more white-matter damage, a sign of small-vessel disease, most clearly in people who did little brisk exercise.[26] No trial has shown that sitting less preserves the brain. One popular explanation, that working muscle releases a brain-growth factor (BDNF) which travels to the brain, doesn't hold up: muscle makes more of it during exercise, but it doesn't appear to enter the blood,[27] and around 70–80% of circulating BDNF comes from the brain itself.[28]
Walking about 7,000 steps a day is linked to 38% lower dementia incidence than 2,000 steps.[29] Aim for 150 minutes or more of aerobic exercise plus two strength sessions a week, and work towards about 7,000 steps a day; every step below that still counts. See Sitting.
Sleep: treat apnea, and don't panic about short nights
Sleep apnea, repeated breathing pauses during sleep, is linked to about 40% higher dementia risk, though few studies accounted for obesity.[30] Treat it with continuous positive airway pressure (CPAP) for its proven benefit on daytime sleepiness. Trials have not shown that CPAP slows cognitive decline: one found no cognitive benefit at six months in 148 middle-aged adults.[31] See Sleep-disordered breathing.
Short sleep is linked to dementia, but the link may run backwards. People sleeping six hours or less are more likely to be diagnosed within the next decade, yet the excess largely disappears in studies following people for longer than that. Short sleep may be an early symptom rather than a cause.[32] Irregular sleep is a newer and still preliminary signal. In one cohort tracked with wrist sensors, the most irregular sleepers had about 50% higher dementia risk over seven years.[33]
The idea that deep sleep washes amyloid out of the brain rests on one 17-person study that moved amyloid but not tau, the other core Alzheimer's protein. Total sleep is a better-supported target than deep sleep. See Sleep architecture. A new habit of long daytime naps (over about an hour, especially in the morning) is more likely an early sign than a cause, and is worth investigating. See Daytime naps.
Aim for 7 to 8 hours on a regular schedule, and get screened for sleep apnea if you have any signs of it.
Diet: the famous number shrank
The "53% lower Alzheimer's risk" for the MIND diet came from an observational study of 923 older adults over four and a half years.[34] Among about 130,000 US nurses and health professionals followed for up to four decades, the best MIND adherence was linked to only about 14% lower dementia risk, and Mediterranean-diet adherence to about 21%.[35] The only randomised trial of the MIND diet, in 604 at-risk older adults over three years, was null: thinking and brain scans did not differ from the control diet.[36]
Ultra-processed food points the other way. Across eight cohorts of more than 250,000 people, the highest intake was linked to about 14% higher risk of cognitive impairment or dementia, clearly in people under 60 but not significantly in those over 60.[37] Whether that is the processing or the poor overall diet these foods come with is still open.[38]
Eat a Mediterranean or MIND-style pattern for your heart: leafy greens, berries, fish, nuts, olive oil, whole grains and beans, with little red and processed meat, fried food, sweets or ultra-processed food. A dementia-specific benefit is unproven. See Dietary patterns.
People, purpose and learning
Social isolation carries about 60% higher dementia risk in the Commission's model, a consistent but observational link, and accounts for about 5% of cases, the largest of the late-life factors.[39] Feeling lonely carries risk of its own: across more than 600,000 people, lonely adults had about 31% higher dementia risk, even after accounting for isolation or depression.[40]
Purpose. In a 28-year study of 4,632 adults, purpose measured at 63 and at 70 predicted about 15% lower odds of a dementia-range score on a telephone screen at about 80; purpose at 52 did not clearly do so, though the estimates overlap.[41] The data are observational and could run backwards, since purpose starts drifting down before memory problems show. The retirement years, when children leave and early widowhood can erode purpose, are a sensible time to pay attention, but no special window has been proven. Plan your next role before the current one ends. See Purpose.
Learning. Education builds reserve. Training improves the skill trained and transfers poorly. In a trial of 2,832 older adults, reasoning and speed training still showed on those skills ten years later.[42] After 20 years, none of the training groups as a whole had significantly fewer dementia diagnoses. Speed-trained people who completed booster sessions were about 25% less likely to be diagnosed, but that group was selected by adherence rather than chance, and one author holds stock in the company selling the training software.[43] Corrected for multiple comparisons, no result stays significant.[44] That fragile signal does not extend to commercial brain-training apps. Real, demanding skills such as a language, music or dancing are a better bet. See Cognitive engagement.
Supplements, drugs and vaccines
Supplements have mostly failed. Pooled trials of omega-3 show essentially no benefit for overall thinking in healthy older adults. A two-year trial of 2 g a day of DHA in 365 low-intake adults, nearly half carrying APOE ε4, raised DHA in spinal fluid but did not change brain volume or cognition, though it was not powered for those outcomes and many dropped out.[45] Vitamin D did not improve thinking in 620 deficient adults with early cognitive impairment,[46] and higher doses in 2,492 older adults did not clearly reduce dementia, though cases were too few to be sure.[47] Correct a vitamin D deficiency for your bones. B vitamins slowed brain shrinkage only in people with mild cognitive impairment and high homocysteine, an amino acid that builds up when B-vitamin status is poor, and in that trial only with adequate omega-3 status, a subgroup finding later trials did not cleanly confirm; routine use without high homocysteine is not supported. See B vitamins. Ginkgo failed two large prevention trials.[48][49] Creatine, resveratrol, curcumin, coconut oil and memory formulas lack convincing trials. A daily multivitamin gave a small gain on thinking tests over two to three years, equivalent to about two years less cognitive ageing, in sub-studies of one industry-supplied trial; that is not a dementia result.[50]
Anti-amyloid drugs (lecanemab, donanemab) slow early symptomatic Alzheimer's modestly. They are not prevention. Over 18 months lecanemab slowed decline by 0.45 points on an 18-point rating scale, about 27% slower.[51] Both drugs cause brain swelling on scans in about 13% (lecanemab) and 24% (donanemab at its original dosing) of patients, mostly without symptoms, with small brain bleeds on top. People with two copies of APOE ε4 are at highest risk, and European licences exclude them. Treatment means regular infusions and repeated MRI scans.
The shingles vaccine probably lowers dementia diagnoses, though by how much is disputed. In Wales, a birthdate cut-off for eligibility created a natural experiment: receiving the vaccine lowered new dementia diagnoses over seven years by 3.5 percentage points, about a fifth.[52] Similar studies in Australia and Canada found that eligibility lowered diagnoses by about 2 percentage points, but so few eligible people were actually vaccinated that two of those results imply more than 100% of dementia prevented in the vaccinated, which is impossible.[53] All of these studies used the older live vaccine, and there is no randomised trial. The vaccine is recommended anyway to prevent shingles, so take it when offered.
Semaglutide is linked to less dementia in people with type 2 diabetes in observational data.[54] In two trials of 3,808 adults with early Alzheimer's, it did not slow decline over two years.[55] Whether starting decades earlier would help is untested. See GLP-1 receptor agonists.
Medicines worth reviewing. The fear that benzodiazepines cause dementia is overstated: in a Dutch cohort of 3,526 older adults, users were no more likely to develop it.[56] A larger cohort agreed overall, but the heaviest users of anti-anxiety benzodiazepines had about 33% higher risk, and current users lost hippocampal volume faster.[57] Avoid long-term, high-dose use anyway, because of falls and dependence. Strongly anticholinergic drugs show a dose-dependent link: in a Swedish study of nearly 200,000 people with dementia, odds rose to about 66% higher after three or more years' worth of standard doses, including for bladder drugs and antihistamines.[58] This is observational, and early dementia may prompt some prescriptions. Where an alternative exists, minimise long-term use of older bladder drugs such as oxybutynin and sedating antihistamines such as diphenhydramine.
What else to do
- Get your hearing screened from age 50: about every five years until 64, then every one to three years from 65, and sooner if you notice a problem.[59]
- Don't smoke, and drink little.
- Wear seatbelts and helmets, and avoid repeated head impacts.
- Cut air-pollution exposure where you can: run a true-HEPA air cleaner in the bedroom every night, which matters most if you live near a major road. See Air purifiers and Environmental toxins.
- Treat depression. It carries the highest individual risk of the 14 factors.
- Family history. Most inherited risk runs through APOE ε4. Testing isn't recommended for healthy adults, because the lifestyle advice is the same whether you carry it or not; it matters if you are considering anti-amyloid treatment. For testing decisions, see a genetic counsellor.
Further reading
- Livingston G et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 2024.[60]
- He J et al. Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial. Nat Med 2025.[61]
- SPRINT MIND Investigators. Effect of intensive vs standard blood pressure control on probable dementia. JAMA 2019.[62]
- Lin FR et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE). Lancet 2023.[63]
- Cribb L et al. Treating hearing loss with hearing aids for the prevention of cognitive decline and dementia. Neurology 2026.[64]
- Ngandu T et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring to prevent cognitive decline in at-risk elderly people (FINGER). Lancet 2015.[65]
- Baker LD et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: the US POINTER randomized clinical trial. JAMA 2025.[66]
- Barnes LL et al. Trial of the MIND diet for prevention of cognitive decline in older persons. N Engl J Med 2023.[67]
- Eyting M et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature 2025.[68]
- van Dyck CH et al. Lecanemab in early Alzheimer's disease. N Engl J Med 2023.[69]
- Sutin AR et al. Purpose in life and cognitive health: a 28-year prospective study. Int Psychogeriatr 2024.[70]
- Erickson KI et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 2011.[71]